Showing results (1-10 of 622) with videos related to
Sort By:
Pageof 63
Current Cardiology Reports|October 21, 2015
New Approaches in Detection and Treatment of Familial HypercholesterolemiaMerel L Hartgers, Kausik K Ray, G Kees HovinghCirculation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.Journal of Atherosclerosis and Thrombosis|December 1, 2017
Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and EuropeMariko Harada-Shiba, John J P Kastelein, G Kees Hovingh, et al.Fundamental & Clinical Pharmacology|November 16, 2007
Biomarkers, C-reactive proteins and statins in acute coronary syndromesKausik K RayLancet (London, England)|August 19, 2014
HDL and cardiovascular diseaseDaniel J Rader, G Kees HovinghNature Reviews. Endocrinology|October 28, 2015
Dyslipidaemia: Lysosomal acid lipase deficiency-a cautious leap forwardCarla E M Hollak, G Kees HovinghCurrent Opinion in Lipidology|October 16, 2020
Proprotein convertase subtilisin/kexin type 9 inhibition as the next statin?Günaj Rakipovski, G Kees Hovingh, Michael NybergCurrent Opinion in Lipidology|January 23, 2018
Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?Andrea Volta, G Kees Hovingh, Aldo GrefhorstCurrent Opinion in Lipidology|January 19, 2016
Non-high-density lipoprotein cholesterol: current status as cardiovascular markerRutger Verbeek, G Kees Hovingh, S Matthijs BoekholdtEuropean Journal of Pharmacology|May 20, 2015
PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemiaRutger Verbeek, Robert M Stoekenbroek, G Kees HovinghPageof 63